REG - Impact Healthcare - Dividend Declaration

Impact Healthcare REITAnnouncement

25/04/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240425:nRSY9221La&default-theme=true

RNS Number : 9221L  Impact Healthcare REIT PLC  25 April 2024

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area, Canada, Australia, Japan or the
Republic of South Africa.

 

25 April 2024

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

DIVIDEND DECLARATION

The Board has today declared the Company's first interim dividend for the year
ending 31 December 2024 of 1.7375 pence per ordinary share, payable on 17(th)
May 2024 to shareholders on the register on 3(rd) May 2024. The ex-dividend
date will be 2(nd) May 2024. This dividend will be paid as a Property Income
Distribution ("PID").

 

This is in line with the Company's target annual dividend for the year to 31
December 2024 of 6.95 pence per share((1)), a 0.18 pence increase from the
prior year, and the Company's dividend policy, which seeks to maintain a
progressive dividend that is covered by its adjusted earnings.

 

The Company expects to report the Group's NAV for the quarter to 31 March 2024
in May 2024 following the Group's Board meeting for the quarter.

Notes:

((1)    )This is a target only and not a profit forecast. There can be no
assurance that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 Impact Health Partners LLP                                                             Via H/Advisors Maitland
 Andrew Cowley
 Mahesh Patel
 David Yaldron

 Jefferies International Limited                                                        +44 20 7029 8000
 Tom Yeadon                                    tyeadon@jefferies.com
 Ollie Nott                                    onott@jefferies.com

 Winterflood Securities Limited                                                         +44 20 3100 0000
 Neil Langford                                 neil.langford@winterflood.com
 Joe Winkley                                   joe.winkley@winterflood.com

 H/Advisors Maitland (Communications advisor)  impacthealth-maitland@h-advisors.global
 James Benjamin                                                                         +44 7747 113 930
 Rachel Cohen                                                                           +44 20 7379 5151
 Billy Moran                                                                            +44 20 7379 5151

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk/) .

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high
quality healthcare real estate assets in the UK and lets these assets on
long-term full repairing and insuring leases to high-quality established
healthcare operators which offer good quality care, under leases which provide
the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable
return, principally in the form of quarterly income distributions and with the
potential for capital and income growth, through exposure to a diversified and
resilient portfolio of UK healthcare real estate assets, in particular care
homes for the elderly.

 

The Company's dividend policy is to maintain a progressive dividend that is
covered by adjusted earnings.

 

On this basis, the target total dividend for the year ending 31 December 2024
is 6.95 pence per share((1)), a 0.18 pence increase over the 6.77 pence in
dividends paid or declared per ordinary share for the year ended 31 December
2023.

 

The Group's Ordinary Shares were admitted to trading on the main market of the
London Stock Exchange, premium segment, on 8 February 2019. The Company is a
constituent of the FTSE EPRA/NAREIT index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVZZGZDVDMGDZM